JP2000503764A - 増殖性動脈疾患の診断および治療におけるrc―9の使用 - Google Patents

増殖性動脈疾患の診断および治療におけるrc―9の使用

Info

Publication number
JP2000503764A
JP2000503764A JP09522889A JP52288996A JP2000503764A JP 2000503764 A JP2000503764 A JP 2000503764A JP 09522889 A JP09522889 A JP 09522889A JP 52288996 A JP52288996 A JP 52288996A JP 2000503764 A JP2000503764 A JP 2000503764A
Authority
JP
Japan
Prior art keywords
antibody
sequence
seq
protein
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP09522889A
Other languages
English (en)
Japanese (ja)
Inventor
オールスタイン,エリオット・ハワード
アーレス,アンソニー・ジョゼフ
オーティーリ,マイケル・ビクター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JP2000503764A publication Critical patent/JP2000503764A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP09522889A 1995-12-18 1996-12-13 増殖性動脈疾患の診断および治療におけるrc―9の使用 Pending JP2000503764A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US880195P 1995-12-18 1995-12-18
US60/008,801 1995-12-18
PCT/US1996/019671 WO1997022880A1 (en) 1995-12-18 1996-12-13 Use of rc-9 in diagnosis and treatment of proliferative arterial disease

Publications (1)

Publication Number Publication Date
JP2000503764A true JP2000503764A (ja) 2000-03-28

Family

ID=21733759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09522889A Pending JP2000503764A (ja) 1995-12-18 1996-12-13 増殖性動脈疾患の診断および治療におけるrc―9の使用

Country Status (5)

Country Link
EP (1) EP0904543A1 (de)
JP (1) JP2000503764A (de)
AU (1) AU1413997A (de)
WO (1) WO1997022880A1 (de)
ZA (1) ZA9610584B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010018870A1 (ja) 2008-08-15 2010-02-18 藤倉化成株式会社 動脈硬化診断用ポリペプチドマーカー、及び該マーカー等を用いる動脈硬化の検出方法、並びに動脈硬化診断用キット

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879883A1 (de) * 1997-05-22 1998-11-25 Smithkline Beecham Corporation ATG-1120 (AIF-1-DELTA), eine Spleissvariante von AIF-1/RC-9
EP0879882A1 (de) * 1997-05-22 1998-11-25 Smithkline Beecham Corporation ATG-1100 (AIF-Gamma), eine Spleissvariante von AIF-1/RC-9
WO2002062839A2 (en) * 2001-02-07 2002-08-15 Universiteit Maastricht Markers of unstable atherosclerotic plaques

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010018870A1 (ja) 2008-08-15 2010-02-18 藤倉化成株式会社 動脈硬化診断用ポリペプチドマーカー、及び該マーカー等を用いる動脈硬化の検出方法、並びに動脈硬化診断用キット
EP3021121A1 (de) 2008-08-15 2016-05-18 Fujikura Kasei Co., Ltd. Polypeptidmarker zur diagnose von arteriosklerose, verfahren für den nachweis von arteriosklerose anhand des markers oder dergleichen und kit für die diagnose von arteriosklerose
US9366681B2 (en) 2008-08-15 2016-06-14 Fujikura Kasei Co., Ltd. Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis

Also Published As

Publication number Publication date
AU1413997A (en) 1997-07-14
EP0904543A1 (de) 1999-03-31
ZA9610584B (en) 1997-06-23
WO1997022880A1 (en) 1997-06-26

Similar Documents

Publication Publication Date Title
DE69933998T2 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
DE69531892T2 (de) Fibroblasten-wachstumsfaktor 10
US6322976B1 (en) Compositions and methods of disease diagnosis and therapy
WO1996026215A1 (en) Ingap protein involved in pancreatic islet neogenesis
JP4111539B2 (ja) 膵島新生に関与するingapタンパク質
US6368794B1 (en) Detection of altered expression of genes regulating cell proliferation
JP2000503764A (ja) 増殖性動脈疾患の診断および治療におけるrc―9の使用
AU645243B2 (en) Human heat shock factor
US6537794B1 (en) Chemokine
US6090580A (en) Interferon responsive transcript (IRT-1)
WO2000046372A2 (en) Pancreatic islet genes regulated by glucose
US20030104418A1 (en) Diagnostic markers for breast cancer
AU708499C (en) Ingap protein involved in pancreatic islet neogenesis
JP2001352991A (ja) βアミロイド蛋白質により発現誘導される新規遺伝子
AU5731500A (en) Gene expression modulated in gastrointestinal inflammation
JP2001258575A (ja) βアミロイドにより誘導できる遺伝子
WO1998033890A1 (en) Human regeneration-associated serpin-1 (rasp-1) and methods of use
JPH1132783A (ja) Hfizg53ポリヌクレオチドおよびポリペプチド
JPH05219959A (ja) 新規なdnaおよびそれによってコードされる蛋白質
MXPA96003897A (en) Factor 10 of fibroblas growth
JPH119287A (ja) Atg−1117(aif−3)、同種異型移植炎症性因子−1/rc−9の新規相同物
JP2002247983A (ja) ヒト血管ibp様成長因子
AU2001232958A1 (en) Modulation of gene expression in formation of fatty atherosclerotic lesions